Bombshell! Apple receives the green light to resume sales of the Apple Watch Series 9 and Ultra in the United States

When it seemed that Apple had everything lost in relation to the possibility of selling Apple Watch Series 9 and Ultra in the North American market due to the ITC ban, the United States Court of Appeals for the Federal Circuit has placed a temporary pause on the ban of the Apple Watch, so technically can re-market them in the United States.

A pause before the new storm

To avoid further problems related to patents and products, the Californian firm stopped sales of the Apple Watch Series 9 and Apple Watch Ultra on its website and in its retail stores last week. The ban came into effect after the Biden administration will refuse to intervenea move that Cupertino hoped would happen, but ultimately did not.

Consequently, he had no choice but to appeal to the United States Court of Appeals for the Federal Circuitwhere it has had a temporary pause, so you will be able to put your devices up for sale again until January 10, 2024.

Along with this, the software department has launched a new update which he believes will solve the patent problem with Masimo. If not, Apple will be in the position of banning its watch section again on January 12 of next year.

Apple's legal disputes with Masimo and AliveCor

Apple Watch Ultra

Apple has been mired in a patent earthquake for several years regarding the sensors of its Apple Watch Series, highlighting confrontations with Masimo and AliveCor. We are going to analyze the situation of both corporations.


Apple Watch Ultra box

AliveCor was one of the first companies to sue Apple for plagiarize your ECG sensors. The reason for arguing the aforementioned theft of information is because both entities met and analyzed the advantages offered by the American company's new sensor. When they were about to reach an agreement, Apple launched the Apple Watch Series 4 including this technology.

Consequently, he had no choice but to sue Apple for theft of technology, intellectual property and monopoly. The latter refers to the complex obstacles that Apple requires to include third-party applications that use the most advanced sensors included in smartwatches. In this sense, although the ITC court ruled in favor of the health company, it did not reach a situation as critical as the one that currently exists with Masimo.


Apple Watch in black

Joe Kiani, founder and CEO of Masimo, states that Apple not only has infringed its patents related to the blood oxygen sensorbut also to steal their technologies by hiring their engineers and executives for data transfer.

3 years ago, the medical-tech company filed a lawsuit in US court alleging that Apple stole trade secrets and infringed patents in 2020 in relation to the Apple Watch, both for the blood oxygen sensor and the pulse oximeter. Likewise, this corporation sued Apple for indicating that these sensors did not at any time replace medical criteria, indicating that this statement is not correct at all, since its technology is proven by a clinician, saving the lives of millions of people.

In conclusion, only time and a court's decision will determine which of the two entities is right, but what is clear is that these movements represent a real setback for the image of the Californian company.